• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

伊伐布雷定对老年犬心房颤动心脏电生理的影响。

Effects of ivabradine on cardiac electrophysiology in dogs with age-related atrial fibrillation.

作者信息

Li Yao-Dong, Ji Yu-Tong, Zhou Xian-Hui, Jiang Tao, Hong Yi-fan, Li Jin-Xin, Xing Qiang, Xiong Jian, Yusufuaji Yueerguli, Tang Bao-Peng

机构信息

Department of Pacing and Electrophysiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China (mainland).

Clinical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China (mainland).

出版信息

Med Sci Monit. 2015 May 16;21:1414-20. doi: 10.12659/MSM.894320.

DOI:10.12659/MSM.894320
PMID:25982136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4444168/
Abstract

BACKGROUND

Ivabradine is an inhibitor of mixed Na+-K+ current that could combine with HCN channels to reduce the transmembrane velocity of funny current (If), heart rate, and cardiac efficiency, and thus be used for the treatment of cardiovascular diseases such as chronic heart failure. As an ion channel blocker, Ivabradine is also a potential antiarrhythmic agent.

MATERIAL/METHODS: Twelve aging dogs (8-10 years old) underwent rapid atrial pacing for 2 months to induce age-related AF in this study. The dogs were randomly divided into the Ivabradine group and aging-AF group. The effects of Ivabradine on the electrophysiological parameters, including the effective refractory period (ERP) of the pulmonary veins and atrium, duration of AF, and inducing rate of AF, were investigated.

RESULTS

As compared to the aging-AF group, the ERPs of the left superior pulmonary vein (139.00±4.18 ms vs. 129.00±4.08 ms, P=0.005) and left auricle (135.00±3.53 ms vs. 122.00±4.47 ms, P=0.001) were significantly increased, while the duration of AF (46.60±5.07 s vs. 205.40±1.14 s, P=0.001) and inducing rate of AF (25% vs. 60%, P=0.001) were significantly decreased.

CONCLUSIONS

Ivabradine could effectively reduce the inducing rate of AF, and thus be used as an upstream drug for the prevention of age-related AF.

摘要

背景

伊伐布雷定是一种混合钠钾电流抑制剂，可与超极化激活的环核苷酸门控通道（HCN通道）结合，降低起搏电流（If）的跨膜速度、心率和心脏效率，从而用于治疗慢性心力衰竭等心血管疾病。作为一种离子通道阻滞剂，伊伐布雷定也是一种潜在的抗心律失常药物。

材料/方法：本研究中，12只8至10岁的老龄犬接受了为期2个月的快速心房起搏以诱导与年龄相关的房颤。这些犬被随机分为伊伐布雷定组和老龄房颤组。研究了伊伐布雷定对电生理参数的影响，包括肺静脉和心房的有效不应期（ERP）、房颤持续时间和房颤诱发率。

结果

与老龄房颤组相比，左上肺静脉的ERP（139.00±4.18毫秒对129.00±4.08毫秒，P = 0.005）和左心耳的ERP（135.00±3.53毫秒对122.00±4.47毫秒，P = 0.001）显著增加，而房颤持续时间（46.60±5.07秒对205.40±1.14秒，P = 0.001）和房颤诱发率（25%对60%，P = 0.001）显著降低。

结论

伊伐布雷定可有效降低房颤诱发率，因此可作为预防与年龄相关房颤的上游药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e2/4444168/5ac8e91f8a6e/medscimonit-21-1414-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e2/4444168/802d4fcfadc8/medscimonit-21-1414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e2/4444168/e7552c454b56/medscimonit-21-1414-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e2/4444168/ab41a0fe69ad/medscimonit-21-1414-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e2/4444168/5e8b719a35b7/medscimonit-21-1414-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e2/4444168/5ac8e91f8a6e/medscimonit-21-1414-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e2/4444168/802d4fcfadc8/medscimonit-21-1414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e2/4444168/e7552c454b56/medscimonit-21-1414-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e2/4444168/ab41a0fe69ad/medscimonit-21-1414-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e2/4444168/5e8b719a35b7/medscimonit-21-1414-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e2/4444168/5ac8e91f8a6e/medscimonit-21-1414-g005.jpg

相似文献

1
Effects of ivabradine on cardiac electrophysiology in dogs with age-related atrial fibrillation.伊伐布雷定对老年犬心房颤动心脏电生理的影响。
Med Sci Monit. 2015 May 16;21:1414-20. doi: 10.12659/MSM.894320.
2
Association between reversal in the expression of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel and age-related atrial fibrillation.超极化激活环核苷酸门控（HCN）通道表达逆转与年龄相关性心房颤动之间的关联
Med Sci Monit. 2014 Nov 14;20:2292-7. doi: 10.12659/MSM.892505.
3
Long-term treatment with ivabradine in transgenic atrial fibrillation mice counteracts hyperpolarization-activated cyclic nucleotide gated channel overexpression.在转基因心房颤动小鼠中，长期使用伊伐布雷定治疗可对抗超极化激活环核苷酸门控通道过表达。
J Cardiovasc Electrophysiol. 2019 Feb;30(2):242-252. doi: 10.1111/jce.13772. Epub 2018 Nov 5.
4
Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation.房室结内 I(f)电流抑制是决奈达隆降低心房颤动心室率的机制。
Heart Rhythm. 2013 Nov;10(11):1692-7. doi: 10.1016/j.hrthm.2013.08.007. Epub 2013 Aug 9.
5
Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.雷诺嗪对完整猪心脏的心房电特性有显著影响，并可缩短房颤持续时间。
J Cardiovasc Electrophysiol. 2009 Jul;20(7):796-802. doi: 10.1111/j.1540-8167.2009.01437.x. Epub 2009 Feb 27.
6
Effect of nifekalant on acute electrical remodelling in rapid atrial pacing canine model.尼非卡兰对快速心房起搏犬模型急性电重构的影响。
Chin Med J (Engl). 2006 Dec 20;119(24):2056-61.
7
Acute ivabradine treatment reduces heart rate without increasing atrial fibrillation inducibility irrespective of underlying vagal activity in dogs.急性伊伐布雷定治疗可降低心率，且不增加犬类房颤的诱发率，无论其潜在的迷走神经活动如何。
Heart Vessels. 2017 Apr;32(4):484-494. doi: 10.1007/s00380-016-0922-y. Epub 2016 Nov 14.
8
Effects of chronic gap junction conduction-enhancing antiarrhythmic peptide GAP-134 administration on experimental atrial fibrillation in dogs.长期给予缝隙连接传导增强型抗心律失常肽GAP-134对犬实验性心房颤动的影响。
Circ Arrhythm Electrophysiol. 2009 Apr;2(2):171-8. doi: 10.1161/CIRCEP.108.790212. Epub 2009 Feb 13.
9
Inefficacy of a highly selective T-type calcium channel blocker in preventing atrial fibrillation related remodeling.高度选择性 T 型钙通道阻滞剂预防房颤相关重构的无效性。
J Cardiovasc Electrophysiol. 2014 May;25(5):531-536. doi: 10.1111/jce.12346. Epub 2014 Jan 30.
10
Difference between electrical remodelling after pulmonary veins and right atrium appendage pacing.肺静脉起搏与右心耳起搏后电重构的差异。
Europace. 2007 Aug;9(8):608-12. doi: 10.1093/europace/eum108. Epub 2007 Jul 13.

引用本文的文献

1
Drug-induced AF: Arrhythmogenic Mechanisms and Management Strategies.药物性房颤：致心律失常机制与管理策略
Arrhythm Electrophysiol Rev. 2024 Apr 3;13:e06. doi: 10.15420/aer.2023.24. eCollection 2024.
2
Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system.抗心律失常药物相关的致心律失常作用：对美国食品药品监督管理局不良事件报告系统的全面不成比例分析
Front Pharmacol. 2023 May 12;14:1170039. doi: 10.3389/fphar.2023.1170039. eCollection 2023.
3
Ivabradine: pre-clinical and clinical evidence in the setting of ventricular arrhythmias.

本文引用的文献

1
Association between reversal in the expression of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel and age-related atrial fibrillation.超极化激活环核苷酸门控（HCN）通道表达逆转与年龄相关性心房颤动之间的关联
Med Sci Monit. 2014 Nov 14;20:2292-7. doi: 10.12659/MSM.892505.
2
Right versus left atrial pacing in patients with sick sinus syndrome and paroxysmal atrial fibrillation (Riverleft study): study protocol for randomized controlled trial.病态窦房结综合征合并阵发性心房颤动患者右心房起搏与左心房起搏的比较（Riverleft研究）：一项随机对照试验的研究方案
Trials. 2014 Nov 17;15:445. doi: 10.1186/1745-6215-15-445.
3
伊伐布雷定：室性心律失常背景下的临床前及临床证据。
Hippokratia. 2022 Apr-Jun;26(2):49-54.
4
Autonomic imbalance and atrial ectopic activity-a pathophysiological and clinical view.自主神经失衡与房性异位活动——病理生理学与临床视角
Front Physiol. 2022 Dec 2;13:1058427. doi: 10.3389/fphys.2022.1058427. eCollection 2022.
5
Management of Chronic Congestive Heart Failure Caused by Myxomatous Mitral Valve Disease in Dogs: A Narrative Review from 1970 to 2020.犬黏液瘤性二尖瓣疾病所致慢性充血性心力衰竭的管理：1970年至2020年的叙述性综述
Animals (Basel). 2022 Jan 16;12(2):209. doi: 10.3390/ani12020209.
6
Ivabradine is as effective as metoprolol in the prevention of ventricular arrhythmias in acute non-reperfused myocardial infarction in the rat.伊伐布雷定可有效预防非再灌注性急性心肌梗死大鼠的室性心律失常，效果与美托洛尔相当。
Sci Rep. 2020 Sep 14;10(1):15027. doi: 10.1038/s41598-020-71706-3.
7
Hyperpolarization-Activated Cyclic Nucleotide-Gated Ion (HCN) Channels Regulate PC12 Cell Differentiation Toward Sympathetic Neuron.超极化激活的环核苷酸门控离子（HCN）通道调节PC12细胞向交感神经元的分化。
Front Cell Neurosci. 2019 Sep 20;13:415. doi: 10.3389/fncel.2019.00415. eCollection 2019.
8
Canine and human sinoatrial node: differences and similarities in the structure, function, molecular profiles, and arrhythmia.犬类和人类的窦房结：结构、功能、分子特征及心律失常方面的差异与相似性
J Vet Cardiol. 2019 Apr;22:2-19. doi: 10.1016/j.jvc.2018.10.004. Epub 2018 Dec 14.
9
Acute effect of ivabradine on heart rate and myocardial oxygen consumption in dogs with asymptomatic mitral valve degeneration.伊伐布雷定对无症状二尖瓣退变犬心率和心肌氧耗的急性影响。
Exp Anim. 2018 Nov 1;67(4):441-449. doi: 10.1538/expanim.18-0030. Epub 2018 May 14.
10
Ion channels, long QT syndrome and arrhythmogenesis in ageing.离子通道、长QT综合征与衰老过程中的心律失常机制
Clin Exp Pharmacol Physiol. 2017 Dec;44 Suppl 1(Suppl Suppl 1):38-45. doi: 10.1111/1440-1681.12721. Epub 2017 Sep 20.
Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.
与伊伐布雷定治疗相关的心房颤动：随机对照试验的荟萃分析
Heart. 2014 Oct;100(19):1506-10. doi: 10.1136/heartjnl-2014-305482. Epub 2014 Jun 20.
4
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure.伊伐布雷定治疗慢性心力衰竭的风险效益评估。
Drug Healthc Patient Saf. 2014 Apr 28;6:47-54. doi: 10.2147/DHPS.S43275. eCollection 2014.
5
The impact of age on the epidemiology of atrial fibrillation hospitalizations.年龄对心房颤动住院患者流行病学的影响。
Am J Med. 2014 Feb;127(2):158.e1-7. doi: 10.1016/j.amjmed.2013.10.005. Epub 2013 Oct 16.
6
Sick sinus syndrome: a review.病态窦房结综合征：综述。
Am Fam Physician. 2013 May 15;87(10):691-6.
7
Increased expression of HCN channels in the ventricular myocardium contributes to enhanced arrhythmicity in mouse failing hearts.心室心肌中 HCN 通道表达增加导致小鼠衰竭心脏心律失常增强。
J Am Heart Assoc. 2013 May 24;2(3):e000150. doi: 10.1161/JAHA.113.000150.
8
Hyperpolarization activated cation current (I(f)) in cardiac myocytes from pulmonary vein sleeves in the canine with atrial fibrillation.犬心房颤动肺静脉袖心肌细胞中的超极化激活阳离子电流（I(f)）。
J Geriatr Cardiol. 2012 Dec;9(4):366-74. doi: 10.3724/SP.J.1263.2012.04161.
9
Atrial fibrillation in the elderly -- not a benign condition.老年人的心房颤动——并非一种良性疾病。
Int Emerg Nurs. 2012 Oct;20(4):221-7. doi: 10.1016/j.ienj.2012.05.003. Epub 2012 Jul 4.
10
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.1993 - 2007年医疗保险受益人心房颤动的发病率、患病率及相关死亡率
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93. doi: 10.1161/CIRCOUTCOMES.111.962688. Epub 2012 Jan 10.